2fqt

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="2fqt" size="450" color="white" frame="true" align="right" spinBox="true" caption="2fqt, resolution 1.79&Aring;" /> '''Crystal structure of...)
Line 1: Line 1:
-
[[Image:2fqt.gif|left|200px]]<br /><applet load="2fqt" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:2fqt.gif|left|200px]]<br /><applet load="2fqt" size="350" color="white" frame="true" align="right" spinBox="true"
caption="2fqt, resolution 1.79&Aring;" />
caption="2fqt, resolution 1.79&Aring;" />
'''Crystal structure of B.subtilis LuxS in complex with (2S)-2-Amino-4-[(2R,3S)-2,3-dihydroxy-3-N-hydroxycarbamoyl-propylmercapto]butyric acid'''<br />
'''Crystal structure of B.subtilis LuxS in complex with (2S)-2-Amino-4-[(2R,3S)-2,3-dihydroxy-3-N-hydroxycarbamoyl-propylmercapto]butyric acid'''<br />
==Overview==
==Overview==
-
S-Ribosylhomocysteinase (LuxS) catalyzes the cleavage of the thioether, linkage in S-ribosylhomocysteine (SRH) to produce homocysteine and, 4,5-dihydroxy-2,3-pentanedione, the precursor of autoinducer 2. Inhibitors, of LuxS should interfere with bacterial interspecies communication and, potentially provide a novel class of antibacterial agents. LuxS utilizes a, divalent metal ion as a Lewis acid during catalysis. In this work, a, series of structural analogues of the substrate SRH and a 2-ketone, intermediate were designed and synthesized. Kinetic studies indicate that, the compounds act as reversible, competitive inhibitors against LuxS, with, the most potent inhibitors having K(I) values in the submicromolar range., These represent the most potent LuxS inhibitors that have been reported to, date. Cocrystal structures of LuxS bound with two of the inhibitors, largely confirmed the design principles, i.e., the importance of both the, homocysteine and ribose moieties in high-affinity binding to the LuxS, active site.
+
S-Ribosylhomocysteinase (LuxS) catalyzes the cleavage of the thioether linkage in S-ribosylhomocysteine (SRH) to produce homocysteine and 4,5-dihydroxy-2,3-pentanedione, the precursor of autoinducer 2. Inhibitors of LuxS should interfere with bacterial interspecies communication and potentially provide a novel class of antibacterial agents. LuxS utilizes a divalent metal ion as a Lewis acid during catalysis. In this work, a series of structural analogues of the substrate SRH and a 2-ketone intermediate were designed and synthesized. Kinetic studies indicate that the compounds act as reversible, competitive inhibitors against LuxS, with the most potent inhibitors having K(I) values in the submicromolar range. These represent the most potent LuxS inhibitors that have been reported to date. Cocrystal structures of LuxS bound with two of the inhibitors largely confirmed the design principles, i.e., the importance of both the homocysteine and ribose moieties in high-affinity binding to the LuxS active site.
==About this Structure==
==About this Structure==
-
2FQT is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bacillus_subtilis Bacillus subtilis] with SO4, CO and H1D as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/S-ribosylhomocysteine_lyase S-ribosylhomocysteine lyase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.4.1.21 4.4.1.21] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2FQT OCA].
+
2FQT is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bacillus_subtilis Bacillus subtilis] with <scene name='pdbligand=SO4:'>SO4</scene>, <scene name='pdbligand=CO:'>CO</scene> and <scene name='pdbligand=H1D:'>H1D</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/S-ribosylhomocysteine_lyase S-ribosylhomocysteine lyase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.4.1.21 4.4.1.21] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FQT OCA].
==Reference==
==Reference==
Line 14: Line 14:
[[Category: S-ribosylhomocysteine lyase]]
[[Category: S-ribosylhomocysteine lyase]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Bell, C.E.]]
+
[[Category: Bell, C E.]]
[[Category: Pei, D.]]
[[Category: Pei, D.]]
[[Category: Rajan, R.]]
[[Category: Rajan, R.]]
Line 25: Line 25:
[[Category: quorum sensing]]
[[Category: quorum sensing]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 10:42:41 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:24:11 2008''

Revision as of 15:24, 21 February 2008


2fqt, resolution 1.79Å

Drag the structure with the mouse to rotate

Crystal structure of B.subtilis LuxS in complex with (2S)-2-Amino-4-[(2R,3S)-2,3-dihydroxy-3-N-hydroxycarbamoyl-propylmercapto]butyric acid

Overview

S-Ribosylhomocysteinase (LuxS) catalyzes the cleavage of the thioether linkage in S-ribosylhomocysteine (SRH) to produce homocysteine and 4,5-dihydroxy-2,3-pentanedione, the precursor of autoinducer 2. Inhibitors of LuxS should interfere with bacterial interspecies communication and potentially provide a novel class of antibacterial agents. LuxS utilizes a divalent metal ion as a Lewis acid during catalysis. In this work, a series of structural analogues of the substrate SRH and a 2-ketone intermediate were designed and synthesized. Kinetic studies indicate that the compounds act as reversible, competitive inhibitors against LuxS, with the most potent inhibitors having K(I) values in the submicromolar range. These represent the most potent LuxS inhibitors that have been reported to date. Cocrystal structures of LuxS bound with two of the inhibitors largely confirmed the design principles, i.e., the importance of both the homocysteine and ribose moieties in high-affinity binding to the LuxS active site.

About this Structure

2FQT is a Single protein structure of sequence from Bacillus subtilis with , and as ligands. Active as S-ribosylhomocysteine lyase, with EC number 4.4.1.21 Full crystallographic information is available from OCA.

Reference

Design and synthesis of substrate and intermediate analogue inhibitors of S-ribosylhomocysteinase., Shen G, Rajan R, Zhu J, Bell CE, Pei D, J Med Chem. 2006 May 18;49(10):3003-11. PMID:16686542

Page seeded by OCA on Thu Feb 21 17:24:11 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools